SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-3 Jul 19, 2018 FORM S-3
8-K Jul 18, 2018 FORM 8-K
SC 13G Jul 18, 2018 SELLAS LIFE SCIENCES GROUP, INC.
424B4 Jul 13, 2018 FORM 424(B)(4)
POS EX Jul 12, 2018 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
EFFECT Jul 11, 2018
S-1MEF Jul 11, 2018 FORM S-1MEF
CORRESP Jul 11, 2018
CORRESP Jul 11, 2018
S-1/A Jul 11, 2018 AMENDMENT NO. 2 TO FORM S-1
CORRESP Jun 28, 2018
CORRESP Jun 26, 2018
CORRESP Jun 26, 2018
S-1/A Jun 26, 2018 AMENDMENT NO. 1 TO FORM S-1
4 Jun 13, 2018 FORM 4 SUBMISSION
4 Jun 13, 2018 FORM 4 SUBMISSION
4 Jun 13, 2018 FORM 4 SUBMISSION
4 Jun 13, 2018 FORM 4 SUBMISSION
4 Jun 13, 2018 FORM 4 SUBMISSION
4 Jun 13, 2018 FORM 4 SUBMISSION
8-K Jun 13, 2018 8-K
8-K Jun 1, 2018 8-K
UPLOAD Jun 1, 2018
8-K May 24, 2018 8-K
DEL AM May 24, 2018 DEL AM
← Newer Page 16 of 51 · 1272 filings Older →